1. World Health Organization . COVID-19 continues to disrupt essential health services in 90% of countries, https://www.who.int/news/item/23-04-2021-covid-19-continues-to-disrupt-essential-health-services-in-90-of-countries (2020, accessed 3 April 2021).
Google Scholar2. Johns Hopkins University (JHU) . COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). The Center for Systems Science and Engineering (CSSE) at JHU, https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 (2021, accessed 11 June 2021).
Google Scholar3. Secretaría de Salud, Gobierno de México . 22° Informe epidemiológico de la situación de COVID-19, 2021, https://www.gob.mx/cms/uploads/attachment/file/643068/Informe_COVID-19_2021.05.31.pdf
Google Scholar4. Garg, S, Kim, L, Whitaker, M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 States, March 1–30, 2020. Morb Mortal Wkly Rep 2020; 69: 458–464, http://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm?s_cid=mm6915e3_w (accessed 11 June 2021).
Google Scholar5. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424, http://doi.wiley.com/10.3322/caac.21492 (accessed 11 June 2021).
Google Scholar6. Corti, C, Curigliano, G. Commentary: SARS-CoV-2 vaccines and cancer patients. Ann Oncol 2021; 32: 569–571, https://linkinghub.elsevier.com/retrieve/pii/S0923753421000107 (accessed 11 June 2021).
Google Scholar7. Webb Hooper, M, Nápoles, AM, Pérez-Stable, EJ. COVID-19 and racial/ethnic disparities. JAMA 2020; 323: 2466–2467, https://jamanetwork.com/journals/jama/fullarticle/2766098 (accessed 11 June 2021).
Google Scholar8. Sosa-Rubí, SG, Seiglie, JA, Chivardi, C, et al. Incremental risk of developing severe COVID-19 among Mexican patients with diabetes attributed to social and health care access disadvantages. Diabetes Care 2021; 44: 373–380, http://care.diabetesjournals.org/lookup/doi/10.2337/dc20-2192 (accessed 11 June 2021).
Google Scholar9. Grivas, P, Khaki, AR, Wise-Draper, TM, et al. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol 2021; 32: 787–800, https://linkinghub.elsevier.com/retrieve/pii/S0923753421008747 (accessed 11 June 2021).
Google Scholar10. Mohar-Betancourt, A, Reynoso-Noverón, N, Armas-Texta, D, et al. Cancer trends in Mexico: essential data for the creation and follow-up of public policies. J Glob Oncol 2017; 3: 740–748, https://ascopubs.org/doi/10.1200/JGO.2016.007476 (accessed 11 June 2021).
Google Scholar11. Campos-Nonato, I, Hernández-Barrera, L, Pedroza-Tobias, A. Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016. Salud Publica Mex 2018; 60: 233–243.
Google Scholar | Crossref | Medline12. Levaillant, M, Lièvre, G, Baert, G. Ending diabetes in Mexico. Lancet 2019; 394: 467–468, https://linkinghub.elsevier.com/retrieve/pii/S0140673619316629 (accessed 11 June 2021).
Google Scholar13. Chapter 1: definition and classification of CKD . Kidney Int Suppl 2013; 3: 19–62, https://linkinghub.elsevier.com/retrieve/pii/S2157171615311011 (accessed 30 July 2021).
Google Scholar14. StataCorp . Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC, 2019, https://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/
Google Scholar15. Yu, J, Ouyang, W, Chua, MLK, et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020; 6: 1108–1110, https://jamanetwork.com/journals/jamaoncology/fullarticle/2763673 (accessed 11 June 2021).
Google Scholar16. Bernabe-Ramirez, C, Velazquez, AI, Olazagasti, C, et al. The HOLA COVID-19 study: an international effort to determine how COVID-19 has impacted oncology practices in Latin America. Cancer Cell 2020; 38: 605–608, https://linkinghub.elsevier.com/retrieve/pii/S1535610820305444 (accessed 11 June 2021).
Google Scholar17. Liang, W, Guan, W, Chen, R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335–357, https://linkinghub.elsevier.com/retrieve/pii/S1470204520300966 (accessed 11 June 2021).
Google Scholar18. Desai, A, Sachdeva, S, Parekh, T, et al. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 2020; 6: 557–559, https://ascopubs.org/doi/10.1200/GO.20.00097 (accessed 13 August 2021).
Google Scholar19. Dai, M, Liu, D, Liu, M, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 2020; 10: 783–791, http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2159-8290.CD-20-0422 (accessed 11 June 2021).
Google Scholar20. Kuderer, NM, Choueiri, TK, Shah, DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020; 395: 1907–1918, https://linkinghub.elsevier.com/retrieve/pii/S0140673620311879 (accessed 11 June 2021).
Google Scholar21. Lee, LY, Cazier, J-B, Angelis, V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020; 395: 1919–1926, https://linkinghub.elsevier.com/retrieve/pii/S0140673620311739 (accessed 11 June 2021).
Google Scholar22. Justo, N, Wilking, N, Jönsson, B, et al. A review of breast cancer care and outcomes in Latin America. Oncologist 2013; 18: 248–256, https://onlinelibrary.wiley.com/doi/abs/10.1634/theoncologist.2012-0373 (accessed 11 June 2021).
Google Scholar23. Al-Salameh, A, Lanoix, J-P, Bennis, Y, et al. The association between body mass index class and coronavirus disease 2019 outcomes. Int J Obes 2021; 45: 700–705, http://www.nature.com/articles/s41366-020-00721-1 (accessed 11 June 2021).
Google Scholar24. Richardson, S, Hirsch, JS, Narasimhan, M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–2059, https://jamanetwork.com/journals/jama/fullarticle/2765184 (accessed 11 June 2021).
Google Scholar25. Li, H, Baldwin, E, Zhang, X, et al. Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform 2021; 28: e100341, https://informatics.bmj.com/lookup/doi/10.1136/bmjhci-2021-100341 (accessed 13 August 2021).
Google Scholar26. Mathelin, C, Ame, S, Anyanwu, S, et al. Breast cancer management during the COVID-19 pandemic: The Senologic International Society Survey. Eur J Breast Health 2021; 17: 188–196, http://cms.galenos.com.tr/Uploads/Article_47125/ejbh-17-188-En.pdf (accessed 16 August 2021).
Google Scholar27. Jee, J, Foote, MB, Lumish, M, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol 2020; 38: 3538–3546, https://ascopubs.org/doi/10.1200/JCO.20.01307 (accessed 16 August 2021).
Google Scholar28. Gandhi, RT. The multidimensional challenge of treating coronavirus disease 2019 (COVID-19): remdesivir is a foot in the door. Clin Infect Dis 2020: ciaa1132, https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1132/5879440 (accessed 11 June 2021).
Google Scholar29. Desai, A, Gupta, R, Advani, S, et al. Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta-analysis of cohort studies. Cancer 2021; 127: 1459–1468.
Google Scholar | Crossref | Medline30. Curigliano, G. Cancer patients and risk of mortality for COVID-19. Cancer Cell 2020; 38: 161–163, https://linkinghub.elsevier.com/retrieve/pii/S1535610820303676 (accessed 13 August 2021).
Google Scholar31. ESMO . Cancer patient management during the COVID-19 pandemic, 2020, https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic
Google Scholar